110 related articles for article (PubMed ID: 20197637)
41. [Repeated intraperitoneal injection of low-dose CDDP for gastric cancer with ascites owing to peritonitis carcinomatosa].
Nakagawa M; Ninomiya M; Fujita I; Matsubara M; Okamoto Y; Kawamoto H; Araki Y; Inoue J; Sasaki H; Takakura N
Gan To Kagaku Ryoho; 2002 Nov; 29(12):2346-9. PubMed ID: 12484071
[TBL] [Abstract][Full Text] [Related]
42. Novel cisplatin-incorporated polymeric micelles can eradicate solid tumors in mice.
Nishiyama N; Okazaki S; Cabral H; Miyamoto M; Kato Y; Sugiyama Y; Nishio K; Matsumura Y; Kataoka K
Cancer Res; 2003 Dec; 63(24):8977-83. PubMed ID: 14695216
[TBL] [Abstract][Full Text] [Related]
43. The improved antitumor efficacy of continuous intratumoral chemotherapy with cisplatin-loaded implants for the treatment of sarcoma 180 tumor-bearing mice.
Gao L; Cai S; Cai A; Zhao Y; Xu T; Ma Y; Xu Y; Wang Y; Wang H; Hu Y
Drug Deliv; 2019 Dec; 26(1):208-215. PubMed ID: 30835582
[TBL] [Abstract][Full Text] [Related]
44. Mobilization of heavy metals by newer, therapeutically useful chelating agents.
Aposhian HV; Maiorino RM; Gonzalez-Ramirez D; Zuniga-Charles M; Xu Z; Hurlbut KM; Junco-Munoz P; Dart RC; Aposhian MM
Toxicology; 1995 Mar; 97(1-3):23-38. PubMed ID: 7716789
[TBL] [Abstract][Full Text] [Related]
45. Preparation and evaluation of a novel liposomal formulation of cisplatin.
Zhou X; Wang J; Wu J; Yang X; Yung BC; Lee LJ; Lee RJ
Eur J Pharm Sci; 2015 Jan; 66():90-5. PubMed ID: 25446511
[TBL] [Abstract][Full Text] [Related]
46. Combination of etanidazole with cyclophosphamide and platinum complexes.
Teicher BA; Herman TS; Shulman L; Bubley G; Coleman CN; Frei E
Cancer Chemother Pharmacol; 1991; 28(3):153-8. PubMed ID: 1830248
[TBL] [Abstract][Full Text] [Related]
47. Cisplatin and curcumin co-loaded nano-liposomes for the treatment of hepatocellular carcinoma.
Cheng Y; Zhao P; Wu S; Yang T; Chen Y; Zhang X; He C; Zheng C; Li K; Ma X; Xiang G
Int J Pharm; 2018 Jul; 545(1-2):261-273. PubMed ID: 29730175
[TBL] [Abstract][Full Text] [Related]
48. Coordination self-assembly of platinum-bisphosphonate polymer-metal complex nanoparticles for cisplatin delivery and effective cancer therapy.
Huang Y; He Y; Huang Z; Jiang Y; Chu W; Sun X; Huang L; Zhao C
Nanoscale; 2017 Jul; 9(28):10002-10019. PubMed ID: 28682411
[TBL] [Abstract][Full Text] [Related]
49. Cadmium inhibits delta-aminolevulinate dehydratase from rat lung in vitro: interaction with chelating and antioxidant agents.
Luchese C; Zeni G; Rocha JB; Nogueira CW; Santos FW
Chem Biol Interact; 2007 Jan; 165(2):127-37. PubMed ID: 17187767
[TBL] [Abstract][Full Text] [Related]
50. Recombinant CD40 ligand therapy has significant antitumor effects on CD40-positive ovarian tumor xenografts grown in SCID mice and demonstrates an augmented effect with cisplatin.
Ghamande S; Hylander BL; Oflazoglu E; Lele S; Fanslow W; Repasky EA
Cancer Res; 2001 Oct; 61(20):7556-62. PubMed ID: 11606394
[TBL] [Abstract][Full Text] [Related]
51. Experimental and clinical evaluation of cisplatin-containing microspheres as intraperitoneal chemotherapy for ovarian cancer.
Sugiyama T; Kumagai S; Nishida T; Ushijima K; Matsuo T; Yakushiji M; Hyon SH; Ikada Y
Anticancer Res; 1998; 18(4B):2837-42. PubMed ID: 9713471
[TBL] [Abstract][Full Text] [Related]
52. Arabinosyl-2-fluoroadenine augments cisplatin cytotoxicity and inhibits cisplatin-DNA cross-link repair.
Yang LY; Li L; Keating MJ; Plunkett W
Mol Pharmacol; 1995 May; 47(5):1072-9. PubMed ID: 7746274
[TBL] [Abstract][Full Text] [Related]
53. In vitro assessment of chelating agents with regard to their abstraction efficiency of Cd(2+) bound to plasma proteins.
Zeini Jahromi E; Gailer J
Metallomics; 2012 Aug; 4(9):995-1003. PubMed ID: 22820874
[TBL] [Abstract][Full Text] [Related]
54. Effects of 2,3-dimercapto-1-propanesulfonic acid (DMPS) on methylmercury-induced locomotor deficits and cerebellar toxicity in mice.
Carvalho MC; Franco JL; Ghizoni H; Kobus K; Nazari EM; Rocha JB; Nogueira CW; Dafre AL; Müller YM; Farina M
Toxicology; 2007 Oct; 239(3):195-203. PubMed ID: 17703864
[TBL] [Abstract][Full Text] [Related]
55. Cisplatin enhances the efficacy of 5-aminolevulinic acid mediated photodynamic therapy in human head and neck squamous cell carcinoma.
Ahn JC; Biswas R; Mondal A; Lee YK; Chung PS
Gen Physiol Biophys; 2014; 33(1):53-62. PubMed ID: 23846261
[TBL] [Abstract][Full Text] [Related]
56. Response of arsenic-induced oxidative stress, DNA damage, and metal imbalance to combined administration of DMSA and monoisoamyl-DMSA during chronic arsenic poisoning in rats.
Bhadauria S; Flora SJ
Cell Biol Toxicol; 2007 Mar; 23(2):91-104. PubMed ID: 17086449
[TBL] [Abstract][Full Text] [Related]
57. [Combined effect of cis-DDP (II), OK-432 and systemic hyperthermia in ascites tumor in mice].
Komatsu K; Nakamura W
Nihon Gan Chiryo Gakkai Shi; 1989 Mar; 24(3):626-37. PubMed ID: 2504850
[TBL] [Abstract][Full Text] [Related]
58. pH-sensitive polymeric cisplatin-ion complex with styrene-maleic acid copolymer exhibits tumor-selective drug delivery and antitumor activity as a result of the enhanced permeability and retention effect.
Saisyo A; Nakamura H; Fang J; Tsukigawa K; Greish K; Furukawa H; Maeda H
Colloids Surf B Biointerfaces; 2016 Feb; 138():128-37. PubMed ID: 26674841
[TBL] [Abstract][Full Text] [Related]
59. Effects of some thiol chelators on enzymatic activities in blood, liver and kidneys of acute arsenic (III) exposed mice.
Tripathi N; Flora SJ
Biomed Environ Sci; 1998 Mar; 11(1):38-45. PubMed ID: 9559101
[TBL] [Abstract][Full Text] [Related]
60. Antitumour activity and side effects of combined treatment with chitosan and cisplatin in sarcoma 180-bearing mice.
Kimura Y; Onoyama M; Sera T; Okuda H
J Pharm Pharmacol; 2000 Jul; 52(7):883-90. PubMed ID: 10933140
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
